{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:46:29Z","timestamp":1791117989867,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ajpath.2012.12.031","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T20:00:18Z","timestamp":1363377618000},"page":"1391-1399","source":"Crossref","is-referenced-by-count":56,"title":["Type I to Type II Ovarian Carcinoma Progression"],"prefix":"10.1016","volume":"182","author":[{"given":"Rong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle M.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.12.031_bib1","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib3","first-page":"679","article-title":"Surface epithelial tumors of the ovary. Blaustein\u2019s pathology of the female genital tract, ed 6","author":"Seidman","year":"2011"},{"key":"10.1016\/j.ajpath.2012.12.031_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2012.12.031_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.ajpath.2012.12.031_bib7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1593\/neo.08784","article-title":"Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations","volume":"10","author":"Sangha","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajpath.2012.12.031_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Network","year":"2011","journal-title":"Nature"},{"issue":"Supplement","key":"10.1016\/j.ajpath.2012.12.031_bib9","first-page":"184A","article-title":"Coexisting tubal intraepithelial carcinoma (TIC) and ovarian serous carcinoma: frequency and implications for the fallopian tube as a source of \u201covarian\u201d serous neoplasia","volume":"86","author":"Kindelberger","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2012.12.031_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/modpathol.2008.197","article-title":"Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma","volume":"22","author":"Jarboe","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2007.049478","article-title":"My approach to and thoughts on the typing of ovarian carcinomas","volume":"61","author":"McCluggage","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/B-catanin and PI3K\/Pten signaling pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2012.12.031_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0090-8258(02)00149-X","article-title":"p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer","volume":"88","author":"Okuda","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2004.01.043","article-title":"Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma","volume":"93","author":"Leitao","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.humpath.2006.10.007","article-title":"Alternate molecular genetic pathways in ovarian carcinomas of common histological types","volume":"38","author":"Willner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0959-8049(95)00636-2","article-title":"Mutant p53 protein as a predictor of survival in endometrial carcinoma","volume":"32A","author":"Strang","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2012.12.031_bib19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1200\/JCO.2008.18.6544","article-title":"PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer","volume":"27","author":"Ogino","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-9048-0","article-title":"PIK3CA mutations in breast cancer are associated with poor outcome","volume":"96","author":"Li","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2012.12.031_bib21","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-11-2410","article-title":"Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review","volume":"18","author":"Liao","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2012.12.031_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.3800992","article-title":"PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters","volume":"21","author":"Catasus","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00428-006-0358-3","article-title":"Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer","volume":"450","author":"Woenckhaus","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2012.12.031_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/humu.9316","article-title":"PIK3CA mutations in advanced ovarian carcinomas","volume":"25","author":"Wang","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2012.12.031_bib25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.humpath.2012.03.011","article-title":"Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma","volume":"43","author":"Rahman","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2559.2009.03283.x","article-title":"High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23-year-old woman","volume":"54","author":"Quddus","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2012.12.031_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0b013e31802cbbe9","article-title":"The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis","volume":"31","author":"Dehari","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAS.0b013e31823732a9","article-title":"Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon","volume":"36","author":"Boyd","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.pgp.0000130049.19643.f6","article-title":"Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases","volume":"23","author":"Parker","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.12.031_bib31","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1158\/1078-0432.CCR-11-1388","article-title":"Preclinical testing of PI3K\/AKT\/mTOR signaling inhibitors in a mouse model of ovarian endometrioid adenocarcinoma","volume":"17","author":"Wu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2012.12.031_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2012.12.031_bib33","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1073\/pnas.052713099","article-title":"Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function","volume":"99","author":"de Vries","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.ajpath.2012.12.031_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.gde.2006.12.003","article-title":"The oncogenic roles of p53 mutants in mouse models","volume":"17","author":"Lozano","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ajpath.2012.12.031_bib35","first-page":"2485","article-title":"Distant metastases in ovarian cancer: association with p53 mutations","volume":"5","author":"Sood","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2012.12.031_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2012.12.031_bib37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.5858\/133.11.1775","article-title":"Ovarian cancer update: lessons from morphology, molecules, and mice","volume":"133","author":"Cho","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajpath.2012.12.031_bib38","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-10-0540","article-title":"A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas","volume":"17","author":"Rudd","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2012.12.031_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1158\/1541-7786.MCR-06-0263","article-title":"Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines","volume":"5","author":"Hollestelle","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ajpath.2012.12.031_bib40","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0701005104","article-title":"Rare cancer-specific mutations in PIK3CA show gain of function","volume":"104","author":"Gymnopoulos","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.031_bib41","first-page":"79","article-title":"Phosphatidylinositol 3-kinase: the oncoprotein","volume":"347","author":"Vogt","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib42","doi-asserted-by":"crossref","first-page":"e4295","DOI":"10.1371\/journal.pone.0004295","article-title":"Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation","volume":"4","author":"Liang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2012.12.031_bib43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1172\/JCI59309","article-title":"An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice","volume":"122","author":"Kinross","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.12.031_bib44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e31824dd86c","article-title":"PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes","volume":"36","author":"Kurek","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib45","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy","volume":"153","author":"Romero","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2012.12.031_bib46","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/bjc.2011.455","article-title":"Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers","volume":"105","author":"Braicu","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2012.12.031_bib47","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1073\/pnas.0712169105","article-title":"Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms","volume":"105","author":"Zhao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.031_bib48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/onc.2012.87","article-title":"PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs","volume":"32","author":"Ross","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2012.12.031_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib50","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib52","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0b013e3182500c1b","article-title":"The differential expression of PAX2 and PAX8 in the ovarian surface epithelium and fallopian tubal epithelium is an important issue","volume":"36","author":"Tong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib53","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/PAS.0b013e3182500c4d","article-title":"PAX2 and PAX8 expression in the ovarian surface epithelium and inclusion cysts","volume":"36","author":"Ozcan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2012.12.031_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1078-0432.CCR-12-2380","article-title":"Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma","volume":"19","author":"Wang","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T15:28:16Z","timestamp":1644593296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002944013000448"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.12.031","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}